Immunotherapy for Gynecological Cancers
Explore the latest advancements in immunotherapy for gynecological cancers in this 55-minute presentation by Dr. Oliver Dorigo from Stanford University. Gain insights into current progress for ovarian, endometrial, and cervical cancer treatments, including recent clinical trial data and promising novel therapeutic approaches. Learn about the cancer-immunity cycle, tumor microenvironment, immune checkpoint inhibitors, and adoptive T cell therapy. Discover the potential of targeted treatments like PD-L1/PD-1 inhibitors and CAR T-cell therapy in improving outcomes for gynecological cancer patients. Understand the impact of HPV-targeted tumor-infiltrating T cells on cervical cancer and the role of tumor-associated antigen-specific T cells in ovarian cancer treatment. Get an overview of ongoing immunotherapy trials and clinical research efforts at Stanford's Gynecologic Oncology Service and Women's Cancer Center.